The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
KIF5B-RET: Discovery of a novel fusion oncogene in lung adenocarcinomas by a systematic screen for tyrosine kinase fusions and identification of patients for a RET targeted therapy trial.
Yoshiyuki Suehara
No relevant relationships to disclose
Maria E. Arcila
No relevant relationships to disclose
Alexander Edward Dela Cruz Drilon
No relevant relationships to disclose
Tatsuo Ito
No relevant relationships to disclose
Lu Wang
No relevant relationships to disclose
Adnan Hasanovic
No relevant relationships to disclose
Raya Khanin
No relevant relationships to disclose
Naiyer A. Rizvi
No relevant relationships to disclose
Marc Ladanyi
No relevant relationships to disclose